DENTSPLY SIRONA Inc.
| Security | XRAY / DENTSPLY SIRONA Inc. |
| Insider | Richard C Rosenzweig |
This page shows the track record and history of ROSENZWEIG RICHARD C
insider trades in DENTSPLY SIRONA Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Richard C Rosenzweig in XRAY / DENTSPLY SIRONA Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Richard C Rosenzweig in XRAY / DENTSPLY SIRONA Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-15 | 2025-07-11 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 595 | 84,417 | ||||||
| 2025-04-15 | 2025-04-11 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 628 | 83,452 | ||||||
| 2025-03-05 | 2025-03-04 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 15.5900 | -1,440 | -22 | 82,823 | ||||
| 2025-03-05 | 2025-03-03 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 15.9900 | -4,956 | -79 | 84,263 | ||||
| 2025-03-05 | 2025-03-03 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 15.9900 | -1,452 | -23 | 89,219 | ||||
| 2025-03-05 | 2025-03-03 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 33,771 | 90,671 | ||||||
| 2025-01-14 | 2025-01-10 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 383 | 56,900 | ||||||
| 2024-10-15 | 2024-10-11 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 267 | 56,208 | ||||||
| 2024-07-15 | 2024-07-12 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 288 | 55,941 | ||||||
| 2024-04-15 | 2024-04-12 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 215 | 55,417 | ||||||
| 2024-03-06 | 2024-03-04 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 11,644 | 55,202 | ||||||
| 2024-03-04 | 2024-03-01 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 33.2700 | -4,736 | -158 | 43,558 | ||||
| 2024-03-04 | 2024-03-01 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 33.2700 | -1,356 | -45 | 48,294 | ||||
| 2024-01-16 | 2024-01-12 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 194 | 49,650 | ||||||
| 2023-10-16 | 2023-10-13 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 201 | 49,291 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 171 | 49,090 | ||||||
| 2023-04-18 | 2023-04-14 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 174 | 48,919 | ||||||
| 2023-03-07 | 2023-03-03 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 38,720 | 48,745 | ||||||
| 2023-03-07 | 2023-03-03 | 4 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 10,003 | 10,025 | ||||||
| 2023-03-02 | 3 | ROSENZWEIG RICHARD C | XRAY | Common Stock | D | 22 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
